Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Massanella

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Iscience|March 31, 2023
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralizationEdwards Pradenas, Silvia Marfil, Víctor Urrea, et al.
Medical Sciences (Basel, Switzerland)|February 20, 2026
Circulating miRNA Signatures Associated with Atherosclerosis and Cardiometabolic Comorbidities in People with HIVMarina Martinez-Velasco, José Francisco Sánchez-Herrero, Laura Ibañez, et al.
The Journal of Clinical Investigation|April 2, 2026
Rapid and profound decay of inducible and intact HIV genomes in early treated Thai childrenMarta Massanella, Caroline Dufour, Amélie Pagliuzza, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2026
Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVIDLourdes Mateu, Louise L Hansen, Joao Pedro Carmezim, et al.
Cell Reports. Medicine|March 2, 2022
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infectionEdwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.
Viruses|June 27, 2025
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 ReinfectionsFrancisco Muñoz-López, Antoni E Bordoy, Francesc Català-Moll, et al.
Plos Computational Biology|April 13, 2019
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir sizeDaniel I S Rosenbloom, Peter Bacchetti, Mars Stone, et al.
Vaccines|July 30, 2025
Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION StudyConcepció Violán, Bibiana Quirant-Sánchez, Maria Palau-Antoja, et al.
Life Science Alliance|August 12, 2022
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional studyEugenia Abella, Macedonia Trigueros, Edwards Pradenas, et al.
Age and Ageing|May 20, 2022
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilitiesMacedonia Trigueros, Edwards Pradenas, Dolors Palacín, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Iscience|March 31, 2023
Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralizationEdwards Pradenas, Silvia Marfil, Víctor Urrea, et al.
Medical Sciences (Basel, Switzerland)|February 20, 2026
Circulating miRNA Signatures Associated with Atherosclerosis and Cardiometabolic Comorbidities in People with HIVMarina Martinez-Velasco, José Francisco Sánchez-Herrero, Laura Ibañez, et al.
The Journal of Clinical Investigation|April 2, 2026
Rapid and profound decay of inducible and intact HIV genomes in early treated Thai childrenMarta Massanella, Caroline Dufour, Amélie Pagliuzza, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 20, 2026
Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVIDLourdes Mateu, Louise L Hansen, Joao Pedro Carmezim, et al.
Cell Reports. Medicine|March 2, 2022
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infectionEdwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.
Viruses|June 27, 2025
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 ReinfectionsFrancisco Muñoz-López, Antoni E Bordoy, Francesc Català-Moll, et al.
Plos Computational Biology|April 13, 2019
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir sizeDaniel I S Rosenbloom, Peter Bacchetti, Mars Stone, et al.
Vaccines|July 30, 2025
Immune Durability and Breakthrough Infections 15 Months After SARS-CoV-2 Boosters in People over 65: The IMMERSION StudyConcepció Violán, Bibiana Quirant-Sánchez, Maria Palau-Antoja, et al.
Life Science Alliance|August 12, 2022
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional studyEugenia Abella, Macedonia Trigueros, Edwards Pradenas, et al.
Age and Ageing|May 20, 2022
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilitiesMacedonia Trigueros, Edwards Pradenas, Dolors Palacín, et al.
Pageof 11